LCC in Mandarin: EGFR in China - From Testing to Treating

Aug 25, 2023
Episode
169
Share

In this special edition of Lung Cancer Considered, three esteemed oncologists and lung cancer experts explore the issues facing clinicians and researchers treating Chinese patients with NSCLC with EGFR mutations.

Guest
Chunxia Su
Chunxia Su

MD, PhD

Deputy Director of the Department of Oncology
Dr. Su is deputy director of the Department of Oncology at the Shanghai Pulmonary Hospital & Thoracic Cancer Institute of the Tongji University School of Medicine in Shanghai, China.
Jie Wang
Jie Wang

MD, PhD

Vice Chief of Medical Oncology
Cancer Hospital Chinese Academy of Medical Science
Yi-Long Wu
Yi-Long Wu

MD

Tenured Professor
Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences

Other Podcast

WCLC 2023 Recap on Lung Cancer Considered
WCLC 2023 Recap
Episode
177
Sep 19, 2023
Live from WCLC Tuesday Highlights
Live from WCLC 2023: Tuesday Highlights
Episode
176
Sep 12, 2023
MARS 2 in Spanish--Monday WCLC Highlights
MARS 2 in Spanish — Monday WCLC Highlights
Episode
175
Sep 11, 2023
Live from WCLC Monday Highlights
Live from WCLC: Monday Highlights
Episode
174
Sep 11, 2023